AstraZeneca pulls EU application for cancer drug
AstraZeneca has pulled its European marketing authorisation application for its non-small cell lung cancer treatment based on the results of a phase III trial.
24 Dec 07:33 · ShareCast
AstraZeneca lung cancer drug Tagrisso approved by EU regulators
AstraZeneca's lung cancer treatment Tagrisso has been approved by European Union regulators on the back of "powerful results" from a phase III trial.
23 Dec 07:31 · ShareCast
last updated on 25 Dec 05:32